Zobrazeno 1 - 10
of 17
pro vyhledávání: '"T P, Vassilakopoulos"'
Autor:
D. Noerenberg, F. Briest, C. Hennch, K. Yoshida, J. Nimo, R. Hablesreiter, Y. Takeuchi, D. Sasca, H. Ueno, L. Mansouri, Y. Inoue, L. Wiegand, A. M. Staiger, B. Casadei, M. Ziepert, F. Asmar, P. Korkolopoulou, M. Kirchner, P. Mertins, J. Weiner, E. Toth, T. Weber, A. Warth, T. Schneider, R.-M. Amini, W. Klapper, M. Hummel, V. Poeschel, G. Kanellis, A. Rosenwald, G. Held, E. Campo, K. Stamatopoulos, I. Anagnostopoulos, L. Bullinger, N. Goldschmidt, P. L. Zinzani, C. Bödor, R. Rosenquist, T. P. Vassilakopoulos, G. Ott, S. Ogawa, F. Damm
Publikováno v:
HemaSphere, Vol 6, Pp 2-3 (2022)
Externí odkaz:
https://doaj.org/article/d54a8cd5040e4d8d8fba3b1b3fbe8223
P1085: EVALUATION OF GONADAL FUNCTION IN YOUNG WOMEN DIAGNOSED WITH HODGKIN AND NON-HODGKIN LYMPHOMA
Autor:
A. N. Georgopoulou, A. Giannakou, T. P. Vassilakopoulos, M. Siakantaris, N. A. Georgopoulos, S. Kalantaridou, E. Lalou, K. Keramaris, E. Loukari, M. Arapaki, I. Konstantinou, A. Machairas, A. Kopsaftopoulou, I. Mammali, I. Vassilopoulos, D. Galopoulos, M. K. Angelopoulou
Publikováno v:
HemaSphere, Vol 6, Pp 975-976 (2022)
Externí odkaz:
https://doaj.org/article/44eb165722294200a5716d10fddbb947
Autor:
A, Velissari, T P, Vassilakopoulos, M K, Angelopoulou, P, Korkolopoulou, G, Bamias, G, Daikos, K, Konstantopoulos, M, Siakantaris
Publikováno v:
Current Research in Translational Medicine. 70:103330
MALT lymphoma is thought to have a genetic component. Genetic studies in the greek population are rare and genetic determinants remain to be established. The current study aimed to seek correlations between genetic polymorphisms and risk of MALT lymp
Autor:
L Papageorgiou, J V Asimakopoulos, V Telonis, A Zannou, P M Arapaki, T Giannikos, E Nikolaou, G Dryllis, I Konstantinou, A Benekou, G Gainarou, P Flevari, E Sinni, P Tsaftaridis, E Plata, T P Vassilakopoulos, M K Angelopoulou, K Konstantopoulos, J Meletis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbee25d0df07986d894a018b7ae72fc8
Autor:
V, Nikolaou, M P, Siakantaris, T P, Vassilakopoulos, E, Papadavid, A, Stratigos, A, Economidi, L, Marinos, T, Papadaki, C, Antoniou
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV. 25(3)
The combination of PUVA with variable doses of systemically administered interferon α2b (IFN-α2b) reduces the number of PUVA treatments and the dose of IFN-α2b required to produce remission in all mycosis fungoides (MF) stages. To evaluate the eff
Autor:
X, Yiakoumis, G A, Pangalis, M-C, Kyrtsonis, T P, Vassilakopoulos, F N, Kontopidou, C, Kalpadakis, P, Korkolopoulou, G, Levidou, A, Androulaki, M P, Siakantaris, S, Sachanas, A, Andreopoulos
Publikováno v:
Anticancer research. 30(1)
Primary effusion lymphoma (PEL) is a rare non-Hodgkin's lymphoma (NHL) mostly occurring in HIV-positive patients. It is characterized by the development of effusion in one or more body cavities, with no tumor masses and a positive human herpes virus-
Autor:
T P, Vassilakopoulos, G, Nadali, M K, Angelopoulou, M N, Dimopoulou, M P, Siakantaris, F N, Kontopidou, C, Karkantaris, S I, Kokoris, E M, Dimitriadou, C, Calpadaki, A, Sarantopoulos, Z, Galani, S, Sachanas, M C, Kyrtsonis, P, Tsaftaridis, E, Variamis, P, Panayotidis, G, Pizzolo, A H, Sarris, G A, Pangalis
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 10(1)
Serum beta-2 microglobulin (sbeta(2)m) is an established prognostic factor for several lymphoproliferative disorders. Because its significance in Hodgkin's lymphoma (HL) is controversial, we determined sbeta(2)m levels in pretreatment serum samples o
Autor:
K, Lilakos, N A, Viniou, D, Mavrogianni, T P, Vassilakopoulos, M N, Dimopoulou, E, Plata, M K, Angelopoulou, E, Variami, N, Stavrogianni, D, Liapi, I, Xilouri, A, Galanopoulos, M, Ageloudi, P, Panayiotidis, M, Voulgarelis, J, Rombos, J, Meletis, X, Yataganas, G A, Pangalis
Publikováno v:
Anticancer research. 26(2A)
Activating mutations of the FLT3 receptor tyrosine kinase are common in acute promyelocytic leukemia (APL) but have uncertain prognostic significance. Information regarding FLT3 expression levels in APL without FLT3 mutations is lacking.Using RT-PCR,
Autor:
T P, Vassilakopoulos, M K, Angelopoulou, M P, Siakantaris, F N, Kontopidou, M N, Dimopoulou, A, Barbounis, V, Grigorakis, C, Karkantaris, K, Anargyrou, M, Chatziioannou, J, Rombos, V A, Boussiotis, G, Vaiopoulos, C, Kittas, G A, Pangalis
Publikováno v:
European journal of haematology. 67(5-6)
Advanced Hodgkin's lymphoma (HL) is curable by conventional chemotherapy in 60--70% of patients. The pretreatment identification of a sizeable subgroup of patients with sufficiently low failure-free survival (FFS) to be eligible for investigational t
Autor:
T P, Vassilakopoulos, G, Nadali, M K, Angelopoulou, M P, Siakantaris, M N, Dimopoulou, F N, Kontopidou, G Z, Rassidakis, I A, Doussis-Anagnostopoulou, M, Hatzioannou, G, Vaiopoulos, C, Kittas, A H, Sarris, G, Pizzolo, G A, Pangalis
Publikováno v:
Haematologica. 86(3)
Interleukin-10 (IL-10) is a pleiotropic cytokine which increases bcl-2 levels and protects cells from steroid or doxorubicin-induced apoptosis. Hodgkin and Reed-Sternberg (HRS) cells bear functional IL-10 receptors. Thus serum IL-10 (sIL-10) might in